Inside Sanofi’s $1B Quest To Make France “Pioneer mRNA Nation”

Sanofi’s scaled-up mRNA development efforts, backed by a $2.2 billion commitment made public in June of last year, are now coming to fruition, with around half of those funds now allocated for transforming the France-based pharma’s home territory into a “pioneer mRNA nation,” the company contends...